Michael Grimley

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

30h-index3.8kcitations236works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(81), Cytomegalovirus and herpesvirus research(40), Virus-based gene therapy research(36), Acute Lymphoblastic Leukemia research(32), Polyomavirus and related diseases(30)

Publications236 total

Bridging the Training Gap for Nurses and Advanced Practice Providers: Addition of in-Situ Simulations for Pediatric Transplant and Cellular Therapy Emergencies
Transplantation and Cellular Therapy·2026
Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide
Transplantation and Cellular Therapy·2026
Evaluating CMV Infection and Reactivation after Emapalumab: A Retrospective Evaluation of Letermovir Prophylaxis
Transplantation and Cellular Therapy·2026
Duration of Cryopreservation of Third-Party Viral Specific T-Cells (TP-VSTs) Does Not Influence Clinical Efficacy
Transplantation and Cellular Therapy·2026
Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease
Blood·2025Open Access
Transcriptomic analysis uncovers hidden intronic and synonymous pathogenic variants in red cell membrane disorders
Blood·2025
Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction
Blood Advances·2025Open Access
Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major
Blood Advances·2025· 2 citedOpen Access
BK polyomavirus genotype IV isolates from virus-specific T-cell therapy recipients
Microbiology Resource Announcements·2025Open Access
Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy
Transplantation and Cellular Therapy·2025· 6 citedOpen Access
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial
Nature Medicine·2025· 9 citedOpen Access
Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation
Bone Marrow Transplantation·2025· 1 cited
Receipt of Fluoroquinolone Prophylaxis is not Associated With Development of Vancomycin-Resistant <i>Enterococcus</i> Colonization During Pediatric Hematopoietic Cell Transplantation
Journal of the Pediatric Infectious Diseases Society·2025· 1 cited
Gene Therapy with Reduced-Intensity Conditioning for Sickle Cell Disease
Transplantation and Cellular Therapy·2025· 1 cited
Effect of Clinically Relevant Immunosuppressants on Viral Specific T-Cell (VST) Function
Transplantation and Cellular Therapy·2025
633. Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period
Open Forum Infectious Diseases·2025Open Access
P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Five-Year Outcomes of the “Abatacept Combined with a Calcineurin Inhibitor and Methotrexate for Graft Versus Host Disease (GVHD) Prophylaxis: A Randomized Controlled Trial” (‘ABA2‘)
Blood·2024Open Access
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season
The Journal of Infectious Diseases·2024· 4 citedOpen Access
Prophylactic VSTs: a promising start but still work to do
Blood Advances·2024Open Access
page 1 of 12Next →

Frequent Co-authors

Stella M. Davies(22), Sonata Jodele(11), Pooja Khandelwal(10), Adam Lane(9), Christopher E. Dandoy(9), Rebecca Marsh(9), Ashish Kumar(9), Carolyn Lutzko(9), Michael B. Jordan(9), Jack Bleesing(8), Kasiani C. Myers(7), Javier El‐Bietar(7), Michael A. Pulsipher(6), Donna A. Wall(6), Jeremy D. Rubinstein(6), Thomas Leemhuis(6), José A. Cancelas(6), Michael D. Keller(6), Catherine M. Bollard(6), Patrick J. Hanley(6)